Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityNo recent work listed

Xue Ying Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4513-3515; OpenAlex author ID A5101593272. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper

Papers 3

  1. Long Intergenic Non-Coding 00162 as Diagnostic Biomarker for Early-Stage Pancreatic Cancer. Last author PMID 36197769↗
  2. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cpr.12805↗
  3. Single and Combined Use of Preoperative Inflammatory Biomarkers and CA199 in Diagnosing Pancreatic Cancer. Last author DOI 10.7754/clin.lab.2020.200111↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mingxing Chen · 1 shared paper, 2022 · strength 0.15
  2. Shanzi Qin · 1 shared paper, 2020 · strength 0.12
  3. Jianhua Ling · 1 shared paper, 2020 · strength 0.12
  4. Kenei Furukawa · 1 shared paper, 2020 · strength 0.12
  5. Lu Yu · 1 shared paper, 2020 · strength 0.12
  6. Jie Fu · 1 shared paper, 2020 · strength 0.12
  7. Yu Lu · 1 shared paper, 2020 · strength 0.12
  8. Paul J. Chiao · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.